GENDER AND BMI-SPECIFIC ANTICHOLINERGIC PERSISTENCE AND ADHERENCE IN PATIENTS WITH OVERACTIVE BLADDER

被引：0
|
作者：
Lua, Lannah [1 ]
Parm, Prathamesh [1 ]
Albanese, Jessica [1 ]
Dandolu, Vani [1 ]
机构：
[1] Univ Nevada, Sch Med, Las Vegas, NV 89154 USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
NM33
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents
    Lua, Lannah L.
    Pathak, Prathamesh
    Dandolu, Vani
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (08) : 2123 - 2131
  • [2] Re: Comparing Anticholinergic Persistence and Adherence Profiles in Overactive Bladder Patients Based on Gender, Obesity, and Major Anticholinergic Agents Editorial Comment
    Lua, L. L.
    Pathak, P.
    Dandolu, V.
    JOURNAL OF UROLOGY, 2018, 200 (05): : 948 - 949
  • [3] Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature
    Sexton, C. C.
    Notte, S. M.
    Maroulis, C.
    Dmochowski, R. R.
    Cardozo, L.
    Subramanian, D.
    Coyne, K. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (05) : 567 - 585
  • [4] Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real-world claims data analysis
    Sussman, D.
    Yehoshua, A.
    Kowalski, J.
    Lee, W.
    Kish, J.
    Chaudhari, S.
    Murray, B.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (3-4)
  • [5] REAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSISREAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSISREAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSISREAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSIS
    Staskin, David
    Chastek, Benjamin
    Carrera, Adam
    Landis, Christina
    Snyder, Daniel
    Abedinzadeh, Laleh
    Bancroft, Tim
    Nesheim, Jeffrey
    NEUROUROLOGY AND URODYNAMICS, 2023, 42 : S164 - S165
  • [6] Drug persistence and adherence in the treatment of overactive bladder
    Radomski, Sidney B.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (9-10): : 351 - 352
  • [7] PERSISTENCE AND COMPLIANCE WITH ANTICHOLINERGIC TREATMENT FOR OVERACTIVE BLADDER IN GERIATRIC POPULATION
    Campeau, Lysanne
    Tamarkina, Elena
    Loutochin, Oleg
    Blok, Bertil
    Corcos, Jacques
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (02) : 156 - 156
  • [8] Comparative persistence and adherence to overactive bladder medications in patients with and without diabetes
    Johnston, S.
    Janning, S. W.
    Haas, G. P.
    Wilson, K. L.
    Smith, D. M.
    Reckard, G.
    Quan, S-P
    Bukofzer, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (11) : 1042 - 1051
  • [9] OVERACTIVE BLADDER MEDICATIONS: COMPARATIVE PERSISTENCE AND ADHERENCE OF PATIENTS WITH AND WITHOUT DIABETES
    Haas, Gabriel
    Johnston, Stephen
    Janning, Stephen
    Wilson, Kathleen
    Smith, David
    Reckard, GinaMarie
    Quan, Shun-Ping
    Bukofzer, Stan
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S257 - S258
  • [10] Persistence with first line anticholinergic medication in treatment-naive overactive bladder patients
    Krhut, Jan
    Gaertner, Marcel
    Petzel, Martin
    Sykora, Radek
    Nemec, David
    Tvrdik, Josef
    Skoupa, Jana
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (01) : 79 - 83
12345